Axonics PE Ratio 2017-2023 | AXNX
Current and historical p/e ratio for Axonics (AXNX) from 2017 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Axonics PE ratio as of April 17, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Axonics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-17 | 67.20 | 0.00 | |
| 2023-12-31 | 62.23 | $-0.13 | 0.00 |
| 2023-09-30 | 56.12 | $-0.25 | 0.00 |
| 2023-06-30 | 50.47 | $-0.67 | 0.00 |
| 2023-03-31 | 54.56 | $-0.99 | 0.00 |
| 2022-12-31 | 62.53 | $-1.30 | 0.00 |
| 2022-09-30 | 70.44 | $-1.65 | 0.00 |
| 2022-06-30 | 56.67 | $-1.69 | 0.00 |
| 2022-03-31 | 62.60 | $-1.81 | 0.00 |
| 2021-12-31 | 56.00 | $-1.88 | 0.00 |
| 2021-09-30 | 65.09 | $-1.83 | 0.00 |
| 2021-06-30 | 63.41 | $-1.69 | 0.00 |
| 2021-03-31 | 59.89 | $-1.64 | 0.00 |
| 2020-12-31 | 49.92 | $-1.50 | 0.00 |
| 2020-09-30 | 51.04 | $-1.96 | 0.00 |
| 2020-06-30 | 35.11 | $-2.61 | 0.00 |
| 2020-03-31 | 25.41 | $-2.75 | 0.00 |
| 2019-12-31 | 27.71 | $-2.79 | 0.00 |
| 2019-09-30 | 26.92 | $-2.54 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.435B | $0.366B |
| Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.189B | 21.80 |
| Inspire Medical Systems (INSP) | United States | $6.715B | 0.00 |
| 10x Genomics (TXG) | United States | $3.670B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.419B | 0.00 |
| Enovis (ENOV) | United States | $3.098B | 23.54 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.818B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.719B | 0.00 |
| Privia Health (PRVA) | United States | $2.099B | 93.11 |
| Schrodinger (SDGR) | United States | $1.790B | 0.00 |
| Phreesia (PHR) | United States | $1.297B | 0.00 |
| Omnicell (OMCL) | United States | $1.224B | 29.94 |
| Definitive Healthcare (DH) | United States | $0.861B | 0.00 |
| Standard BioTools (LAB) | United States | $0.786B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.620B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.324B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.310B | 0.00 |
| Pulmonx (LUNG) | United States | $0.286B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.187B | 0.00 |
| Augmedix (AUGX) | United States | $0.168B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.149B | 0.00 |
| American Well (AMWL) | United States | $0.149B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
| TruBridge (TBRG) | United States | $0.122B | 5.22 |
| Outset Medical (OM) | United States | $0.108B | 0.00 |
| 111 (YI) | China | $0.084B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.076B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.074B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Akili (AKLI) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.017B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |